CSRP3 Gene Cardiomyopathy Dilated Type 1M NGS Genetic DNA Test
Understanding CSRP3 Gene Cardiomyopathy Testing
The CSRP3 Gene Cardiomyopathy Dilated Type 1M NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering comprehensive analysis of the CSRP3 gene mutations responsible for inherited dilated cardiomyopathy. This condition affects the heart’s ability to pump blood effectively, potentially leading to heart failure and life-threatening complications if left undetected.
What This Advanced Genetic Test Measures
Our state-of-the-art NGS (Next-Generation Sequencing) technology examines the CSRP3 gene for specific mutations known to cause dilated cardiomyopathy type 1M. The test identifies:
- Pathogenic variants in the CSRP3 gene sequence
- Single nucleotide polymorphisms associated with cardiac dysfunction
- Deletion and duplication mutations affecting muscle protein function
- Genetic markers indicating increased risk for progressive heart enlargement
Who Should Consider CSRP3 Genetic Testing?
This test is particularly important for individuals experiencing:
- Unexplained shortness of breath or fatigue during normal activities
- Family history of cardiomyopathy or sudden cardiac death
- Abnormal heart rhythms or palpitations without clear cause
- Swelling in legs, ankles, or feet due to fluid retention
- Persistent cough or wheezing when lying down
- Rapid weight gain from fluid buildup
- Dizziness, lightheadedness, or fainting episodes
- Heart murmurs detected during physical examinations
Clinical Benefits of Early Detection
Early identification of CSRP3 gene mutations provides numerous advantages:
- Enables proactive management of cardiac health before symptoms worsen
- Guides appropriate medication and treatment strategies
- Informs family members about potential inherited risks
- Facilitates lifestyle modifications to protect heart function
- Supports family planning decisions with genetic counseling
- Reduces anxiety through definitive diagnosis
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation of your results:
- Positive Result: Indicates presence of CSRP3 mutation – requires consultation with cardiologist and genetic counselor for management plan
- Negative Result: No detected mutation – provides reassurance but continued cardiac monitoring may be recommended based on family history
- Variant of Uncertain Significance: Requires additional family studies and periodic re-evaluation as research advances
Test Pricing and Availability
| Test Feature | Details |
|---|---|
| Test Name | CSRP3 Gene Cardiomyopathy Dilated Type 1M NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Availability
We provide comprehensive cardiac genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and cardiology specialists ensures you receive expert care regardless of your location.
Take Control of Your Cardiac Health Today
Don’t wait for symptoms to progress. Early detection of CSRP3 gene mutations can significantly impact your long-term heart health and quality of life. Our experienced team is ready to guide you through the testing process and provide the answers you need for informed healthcare decisions.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your CSRP3 genetic test consultation and take the first step toward proactive cardiac care.
